← Back to screener

Merck & Co., Inc. MRK

Rank #2141 · NYSE · $369.3B market cap
Audited by PricewaterhouseCoopers LLP, no going-concern flag in the latest filing.
Score
32.3
P/E
1011.7
P/B
7.97
ROE
0.8%
Op. Margin
–%
Debt Ratio
153%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★☆☆☆☆
Weak

P/E 1011.7x, P/B 7.97x. Ranks in the top 70% of the universe.

Profitability ★★☆☆☆
Weak

ROE 0.8%. Ranks in the top 68% of the universe.

Safety ★★☆☆☆
Average

Debt ratio 153%. Ranks in the top 54% of the universe.

Growth ★★☆☆☆
Average

Revenue growth of 1.4% year over year. Ranks in the top 60% of the universe.

Profitability is the relative strength · Valuation is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FYRevenueOp. IncomeNet IncomeEquityOp. Margin%Debt%
2011––$12.9B$54.4B–95
2012––$0.9B$54.5B–93
2013––$6.3B$53.0B–100
2014––$6.2B$49.8B–112
2015––$4.4B$48.6B–102
2016––$11.9B$44.7B–128
2017––$4.4B$40.1B–138
2018$39.8B–$3.9B$34.3B–156
2019$40.1B–$2.4B$26.7B–209
2020$42.3B–$6.2B$25.9B–226
2021$39.1B–$9.8B$25.3B–262
2022$41.5B–$7.1B$38.2B–177
2023$48.7B–$13.0B$46.0B–137
2024$59.3B–$14.5B$37.6B–184
2025$60.1B–$0.4B$46.3B–153

← See the full screener